基本信息
views: 2
Career Trajectory
Bio
Areas of Interest:
The research in my laboratory is focused on developing biomarkers that can be used for individual risk assessment, early detection, and therapeutic monitoring of cancer. To reach this goal, we have two specific research areas: The first area of research is to study the molecular basis of tumor morphogenesis, we focus our effort on investigating how cytoskeletal proteins, specifically the microfilament actin and the associated binding proteins, are altered in tumorigenesis. We hypothesize that since tumor cells have morphological features that are distinctive from normal cells, and since actin family proteins play important roles in regulating cell morphology, adhesion, as well as motility, investigating these protein changes during tumorigenesis will not only provide molecular insight for tumor morphology, but at the same time develop surrogate markers that are more sensitive and specific than morphological analysis alone. Since actin network is regulated by multiple complex oncogenic signal transduction events, including Ras superfamily small G proteins Rac/Rho/Cdc42, and Src family proteins, and many of these proteins have been developed as the potential therapeutic targets, it is possible that an actin centric strategy for cancer detection/monitoring/prevention/therapy can be developed in he future. Our second area of research is to develop approaches that can be used to detect early malignant lesions, especially cancer of the breast, bladder, and prostate. The detection of low stage malignant and premalignant lesions is essential for the successful halt, or even the reversion of malignant progression through chemoprevention strategy. The focus will be to develop simple, high throughput techniques that can be used to detect expressional abnormalities of multiple genes on a small sample volume basis. One specific example is to develop Quantitative Fluorescence Image Analysis (QFIA) as a single-cell proteomic method for biomarker analysis on cytological materials. Recently, collaborating with investigators from California Nanosystem Institute, we have investigated the possibility of nanomechanical profiles as markers for not only detecting cancer cells, but providing prognostic and therapeutic information to guide cancer management at individual patient level.
The research in my laboratory is focused on developing biomarkers that can be used for individual risk assessment, early detection, and therapeutic monitoring of cancer. To reach this goal, we have two specific research areas: The first area of research is to study the molecular basis of tumor morphogenesis, we focus our effort on investigating how cytoskeletal proteins, specifically the microfilament actin and the associated binding proteins, are altered in tumorigenesis. We hypothesize that since tumor cells have morphological features that are distinctive from normal cells, and since actin family proteins play important roles in regulating cell morphology, adhesion, as well as motility, investigating these protein changes during tumorigenesis will not only provide molecular insight for tumor morphology, but at the same time develop surrogate markers that are more sensitive and specific than morphological analysis alone. Since actin network is regulated by multiple complex oncogenic signal transduction events, including Ras superfamily small G proteins Rac/Rho/Cdc42, and Src family proteins, and many of these proteins have been developed as the potential therapeutic targets, it is possible that an actin centric strategy for cancer detection/monitoring/prevention/therapy can be developed in he future. Our second area of research is to develop approaches that can be used to detect early malignant lesions, especially cancer of the breast, bladder, and prostate. The detection of low stage malignant and premalignant lesions is essential for the successful halt, or even the reversion of malignant progression through chemoprevention strategy. The focus will be to develop simple, high throughput techniques that can be used to detect expressional abnormalities of multiple genes on a small sample volume basis. One specific example is to develop Quantitative Fluorescence Image Analysis (QFIA) as a single-cell proteomic method for biomarker analysis on cytological materials. Recently, collaborating with investigators from California Nanosystem Institute, we have investigated the possibility of nanomechanical profiles as markers for not only detecting cancer cells, but providing prognostic and therapeutic information to guide cancer management at individual patient level.
Research Interests
Papers共 280 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
SURGERYno. 1 (2024): 221-227
Journal of the National Comprehensive Cancer Networkno. 2.5 (2024)
Douglas D. Lim,Jianyu Rao
CMAS Journal (2024)
NUTRIENTSno. 6 (2024)
Nicola S. Meagher,Kylie L. Gorringe,Matthew Wakefield,Adelyn Bolithon,Chi Nam Ignatius Pang,Derek S. Chiu,Michael S. Anglesio, Kylie-Ann Mallitt,Jennifer A. Doherty,Holly R. Harris,Joellen M. Schildkraut,Andrew Berchuck,Kara L. Cushing-Haugen,Ksenia Chezar,Angela Chou,Adeline Tan,Jennifer Alsop,Ellen Barlow,Matthias W. Beckmann,Jessica Boros,David D.L. Bowtell,Alison H. Brand,James D. Brenton,Ian Campbell,Dane Cheasley,Joshua Cohen,Cezary Cybulski, Esther Elishaev,Ramona Erber,Rhonda Farrell,Anna Fischer,Zhuxuan Fu,Blake Gilks,Anthony J. Gill,Charlie Gourley,Marcel Grube,Paul R. Harnett,Arndt Hartmann,Anusha Hettiaratchi,Claus K. Høgdall,Tomasz Huzarski, Anna Jakubowska,Mercedes Jimenez-Linan,Catherine J. Kennedy,Byoung-Gie Kim, Jae-Weon Kim, Jae-Hoon Kim, Kayla Klett,Jennifer M. Koziak,Tiffany Lai,Angela Laslavic,Jenny Lester,Yee Leung,Na Li,Winston Liauw,Belle W.X. Lim,Anna Linder, Jan Lubiński,Sakshi Mahale,Constantina Mateoiu,Simone McInerny,Janusz Menkiszak,Parham Minoo,Suzana Mittelstadt,David Morris,Sandra Orsulic,Sang-Yoon Park,Celeste Leigh Pearce,John V. Pearson,Malcolm C. Pike,Carmel M. Quinn,Ganendra Raj Mohan,Jianyu Rao,Marjorie J. Riggan,Matthias Ruebner,Stuart Salfinger,Clare L. Scott,Mitul Shah,Helen Steed, Colin J.R. Stewart,Deepak Subramanian,Soseul Sung,Katrina Tang,Paul Timpson,Robyn L. Ward, Rebekka Wiedenhoefer,Heather Thorne,Paul A. Cohen,Philip Crowe, Peter A. Fasching,Jacek Gronwald, Nicholas J. Hawkins,Estrid Høgdall,David G. Huntsman,Paul A. James,Beth Y. Karlan, Linda E. Kelemen,Stefan Kommoss,Gottfried E. Konecny,Francesmary Modugno, Sue K. Park,Annette Staebler,Karin Sundfeldt,Anna H. Wu,Aline Talhouk,Paul D.P. Pharoah,Lyndal Anderson,Anna DeFazio, Martin Köbel,Michael L. Friedlander,Susan J. Ramus
crossref(2023)
openalex(2023)
Jenny T. Mao,Michael D. Roth,Michael C. Fishbein,Denise R. Aberle,Zuo-Feng Zhang,Jian Yu Rao,Donald P. Tashkin,Lee Goodglick, E. Carmack Holmes, Robert B. Cameron,Steven M. Dubinett, Robert Elashoff,Eva Szabo,David Elashoff
crossref(2023)
Load More
Author Statistics
#Papers: 282
#Citation: 10175
H-Index: 48
G-Index: 95
Sociability: 7
Diversity: 0
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn